Catalyst Pharmaceuticals is a commercial-stage, patient-centric biopharmaceutical company focused on in-licensing, developing, and commercializing novel high-quality medicines for patients living with rare diseases. With exceptional patient focus, Catalyst is committed to developing a robust pipelin... Read more
View all
TRICIDA
South San Francisco, United States · Post IPO Debt
Emmaus Medical
Torrance, United States · Post IPO Equity
Spectrum Pharmaceuticals
Henderson, United States · Post IPO Debt
DURECT
Cupertino, United States · Post IPO Equity
Insys Therapeutics
Phoenix, United States · Post IPO Equity
Alimera Sciences
Alpharetta, United States · Post IPO Equity
Adamas Pharmaceuticals
Emeryville, United States · Post IPO Equity
Sezzle
Minneapolis, United States · Post IPO Debt
Embark Trucks
San Francisco, United States · Post IPO Equity
Bolt Biotherapeutics
Redwood City, United States · Post IPO Equity
Pulse Biosciences
Hayward, United States · Post IPO Equity
Owlet Baby Care
Lehi, United States · Post IPO Equity